Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
Yoshiro Fushimi(Kawasaki Medical School), Hideaki Kaneto(Kawasaki Medical School)
Cited by 15
Related Papers
Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia
|Diabetes|2007|369
Involvement of Protein Kinase C β2 in c-mycInduction by High Glucose in Pancreatic β-Cells
|Journal of Biological Chemistry|2002|58